Cargando…

Management dilemmas in pulmonary arterial hypertension associated with congenital heart disease

There are few randomised controlled data to guide management of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD). In this clinical review, common areas of uncertainty in the management of PAH-CHD are identified, the literature is summarised and discuss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Condliffe, R., Clift, P., Dimopoulos, K., Tulloh, R.M.R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161209/ https://www.ncbi.nlm.nih.gov/pubmed/30033821 http://dx.doi.org/10.1177/2045894018792501

Ejemplares similares

Congenital heart disease, pulmonary arterial hypertension and the UK’s Drivers and Vehicle Licensing Agency: controversial new guidance
por: Constantine, Andrew, et al.
Publicado: (2019)

Palliative care in pulmonary hypertension associated with congenital heart disease: systematic review and expert opinion
por: Constantine, Andrew, et al.
Publicado: (2021)

Pulmonary hypertension in congenital heart disease
por: Pascall, Emma, et al.
Publicado: (2018)

Cortisol/cortisone levels and quality of life in individuals with pulmonary arterial hypertension
por: Tulloh, RMR, et al.
Publicado: (2020)

Lung Function, Inflammation, and Endothelin‐1 in Congenital Heart Disease–Associated Pulmonary Arterial Hypertension
por: Low, Andrew, et al.
Publicado: (2018)

Effect of dual pulmonary vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease: a retrospective analysis
por: Monfredi, Oliver, et al.
Publicado: (2016)

Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United Kingdom
por: Constantine, Andrew, et al.
Publicado: (2021)

Better Outcomes in Pulmonary Arterial Hypertension After Repair of Congenital Heart Disease, Compared With Idiopathic Pulmonary Arterial Hypertension
por: Xu, Zhuoyuan, et al.
Publicado: (2021)

Evaluation and Management of Pulmonary Arterial Hypertension in Congenital Heart Disease
por: Arshad, Hassaan B., et al.
Publicado: (2021)

Connective tissue disease-associated pulmonary arterial hypertension
por: Condliffe, Robin, et al.
Publicado: (2015)

Riociguat for pulmonary arterial hypertension associated with congenital heart disease
por: Rosenkranz, Stephan, et al.
Publicado: (2015)

Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Savale, Laurent, et al.
Publicado: (2019)

Pulmonary arterial hypertension associated with congenital heart disease: An omics study
por: Zhao, Maolin, et al.
Publicado: (2023)

Haemoptysis in Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: Insights on Pathophysiology, Diagnosis and Management
por: Baroutidou, Amalia, et al.
Publicado: (2022)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with congenital heart disease
por: Lopes, Antonio, et al.
Publicado: (2014)

Plasma Proteomic Study in Pulmonary Arterial Hypertension Associated with Congenital Heart Diseases
por: Zhang, Xi, et al.
Publicado: (2016)

Management dilemmas in acute pulmonary embolism
por: Condliffe, Robin, et al.
Publicado: (2014)

Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease
por: Zhu, Na, et al.
Publicado: (2018)

Comparison of 18F-FDG uptake by right ventricular myocardium in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Fang, Wei, et al.
Publicado: (2012)

Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2018)

The Changing Landscape of Pulmonary Arterial Hypertension in the Adult with Congenital Heart Disease
por: van Dissel, Alexandra C., et al.
Publicado: (2017)

Anesthetic management of pediatric with congenital heart disease with pulmonary hypertension
por: Singh, Dipika, et al.
Publicado: (2014)

Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
por: Gu, Li, et al.
Publicado: (2020)

Platelet Activation Markers in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
por: Awad, Abdulhalim, et al.
Publicado: (2022)

Risk Assessment Tool Implementation in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension
por: Yaylalı, Yalın Tolga, et al.
Publicado: (2023)

Changes in contractile protein expression are linked to ventricular stiffness in infants with pulmonary hypertension or right ventricular hypertrophy due to congenital heart disease
por: Bond, Andrew R, et al.
Publicado: (2018)

Editorial: Pulmonary hypertension associated with congenital heart disease
por: He, Siyi, et al.
Publicado: (2023)

Effect of Dexmedetomidine on Pulmonary Artery Pressure in Children with Congenital Heart Disease and Pulmonary Hypertension
por: Kanchi, Muralidhar, et al.
Publicado: (2020)

Pulmonary vasodilators can lead to various complications in pulmonary “arterial” hypertension associated with congenital heart disease
por: Chida-Nagai, Ayako, et al.
Publicado: (2020)

Recent progress in treatment of pulmonary arterial hypertension due to congenital heart disease
por: Schuuring, M. J., et al.
Publicado: (2011)

Effect of iloprost on biomarkers in patients with congenital heart disease‐pulmonary arterial hypertension
por: Li, Xiao‐ye, et al.
Publicado: (2017)

Prognostic value of multiple repeated biomarkers in pulmonary arterial hypertension associated with congenital heart disease
por: van Dissel, Alexandra C., et al.
Publicado: (2018)

Pulmonary Arterial Hypertension Associated with Congenital Heart Disease in Adults over the Age of 40 Years
por: Maurer, Susanne J., et al.
Publicado: (2020)

Treatment of pediatric pulmonary hypertension
por: Hawkins, Amy, et al.
Publicado: (2009)

Advanced therapies for the management of adults with pulmonary arterial hypertension due to congenital heart disease: a systematic review
por: Varela, Daniel L, et al.
Publicado: (2018)

Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension
por: Pfarr, Nicole, et al.
Publicado: (2013)

Contemporary use of Selexipag in pulmonary arterial hypertension associated with congenital heart disease: a case series
por: Blissett, Sarah, et al.
Publicado: (2020)

Altered Lung Microbiome and Metabolome Profile in Children With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease
por: Ma, Runwei, et al.
Publicado: (2022)

Use of the index of pulmonary vascular disease for predicting long-term outcome of pulmonary arterial hypertension associated with congenital heart disease
por: Chida-Nagai, Ayako, et al.
Publicado: (2023)

The expression of survivin in irreversible pulmonary arterial hypertension rats and its value in evaluating the reversibility of pulmonary arterial hypertension secondary to congenital heart disease
por: Li, Gang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qekec40s2eh6en2i9no61d6r5p